Hermetica Superfood Encyclopedia
The Short Answer
Zanthoxylum rhoifolium leaf essential oils are dominated by sesquiterpenes and monoterpenes — principally germacrene D (14.6%), limonene (12.5%), and β-elemene (9.2%) — alongside alkaloids identified in stem bark and leaf extracts whose precise analgesic mechanisms remain uncharacterized at the molecular level. Current evidence is limited to phytochemical profiling and a brine shrimp (Artemia salina) lethality bioassay; no clinical analgesic efficacy data exist for this specific species in human or mammalian models.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordHercules Club Zanthoxylum rhoifolium benefits
Hercules' Club — botanical close-up
Health Benefits
**Potential Analgesic Activity**
Traditional use within the broader Zanthoxylum genus supports pain-relieving properties; alkaloids isolated from stem bark and leaf extracts of Z. rhoifolium are hypothesized to contribute to numbing or analgesic effects, though direct mechanistic evidence for this species is absent.
**Phytochemical Diversity**
Gas chromatography-mass spectrometry analysis of leaf essential oils identified at least eight major volatile constituents, and fractionation of bark and leaf extracts yielded 29 compounds including three novel structures, indicating rich secondary metabolite diversity with unexplored bioactivity.
**Cytotoxicity Screening (Brine Shrimp)**
Essential oils demonstrated lethality against Artemia salina in a standard cytotoxicity bioassay, a preliminary surrogate screen used in natural product research to flag compounds warranting further investigation for bioactive potential.
**Anti-inflammatory Potential (Class-Level)**
Related Zanthoxylum species produce benzophenanthridine alkaloids such as chelerythrine and alkamides like hydroxy-α-sanshool, compound classes known to modulate inflammatory pathways; Z. rhoifolium shares genus-level alkaloid chemistry that may confer analogous properties pending confirmation.
**Antimicrobial Considerations**: While Z
rhoifolium essential oils showed no activity against Bacillus cereus, Staphylococcus aureus, Pseudomonas aeruginosa, or Escherichia coli in in vitro screening, the alkaloid-rich bark fractions have not been independently tested for antimicrobial activity and represent an uncharacterized area of the species' profile.
**Terpene-Mediated Bioactivity**
Germacrene D and bicyclogermacrene, together comprising over 22% of the leaf essential oil, belong to sesquiterpene classes reported in other botanical contexts to possess anti-inflammatory and mild analgesic properties, providing a rationale for traditional pain-use claims at the compound-class level.
**Traditional Ethnobotanical Relevance**
Within the broader Amazonian pharmacopoeia, Zanthoxylum species are employed for toothache, fever, and rheumatic pain; Z. rhoifolium occupies a plausible ethnopharmacological niche in this tradition, though species-specific indigenous documentation remains sparse in the published literature.
Origin & History
Natural habitat
Zanthoxylum rhoifolium is a thorny tree native to tropical and subtropical regions of Central and South America, including Costa Rica and the broader Amazonian basin, where it grows in secondary forests and forest margins. It belongs to the Rutaceae (citrus) family and thrives in humid, lowland tropical conditions with well-drained soils. Botanical specimens used in phytochemical research have been collected primarily from Costa Rica, though the species range extends through much of neotropical South America.
“Zanthoxylum rhoifolium's specific ethnobotanical history is poorly documented in the scientific literature, with published phytochemical studies focusing on Costa Rican botanical specimens without recording local indigenous or traditional medicinal applications. The broader Zanthoxylum genus has a well-established cross-cultural use history: in North America, Z. clava-herculis (also called Hercules' Club or toothache tree) was used by Cherokee, Rappahannock, and other Native American peoples who chewed the bark and root to relieve toothache and oral pain through the numbing properties of its alkamide constituents. In South American and Amazonian traditions, various Zanthoxylum species are employed in folk medicine for fever reduction, rheumatic pain, and as tonics, placing Z. rhoifolium within a pharmacologically plausible ethnobotanical context even where species-specific records are absent. The common name 'Hercules' Club' applied to multiple Zanthoxylum species across the Americas reflects the characteristic large thorns on the bark and trunk, which historically drew attention to these trees as medicinally and practically significant in their respective cultural environments.”Traditional Medicine
Scientific Research
The scientific evidence base for Zanthoxylum rhoifolium is extremely limited and consists almost entirely of phytochemical characterization studies rather than pharmacological or clinical investigations. Published research includes gas chromatography-mass spectrometry profiling of leaf essential oils collected from Costa Rican specimens and a secondary metabolite isolation study reporting 29 compounds from bark and leaf fractions including three previously undescribed structures, but no peer-reviewed clinical trials or controlled animal studies specific to Z. rhoifolium have been identified. In vitro bioactivity screening of the essential oils returned negative results for cytotoxicity against HepG2 (liver carcinoma), MCF-7 (breast carcinoma), and PC-3 (prostate carcinoma) cell lines and for antibacterial activity against four standard bacterial strains, with the sole positive signal being Artemia salina lethality, which is a low-specificity preliminary screen. The overall evidence level is preclinical and predominantly descriptive; no quantified therapeutic outcomes, dose-response relationships, or mammalian safety data have been reported in peer-reviewed literature for this species.
Preparation & Dosage
Traditional preparation
**Traditional Bark Preparation**
Aromatic bark or root bark of related Hercules' Club species is traditionally chewed raw or prepared as a decoction for localized oral analgesia; no validated preparation method specific to Z. rhoifolium exists in the literature.
**Essential Oil (Research Grade)**
Leaf essential oils have been extracted via hydrodistillation in research settings; no commercial standardized essential oil product for Z. rhoifolium is currently established or dosed.
**Bark/Leaf Extract (Experimental)**
Apolar and medium-polarity fractions have been prepared using solvent extraction in phytochemical studies; no standardized extract percentage, minimum effective dose, or supplement form is commercially available.
**Standardization**
No standardization benchmarks (e.g., percent germacrene D, alkaloid content) have been established for Z. rhoifolium in any supplement context.
**Effective Dose Range**
No evidence-based effective dose range exists; the ingredient is not recognized as a standardized nutritional supplement and should not be self-dosed pending further safety and pharmacokinetic characterization.
Nutritional Profile
Zanthoxylum rhoifolium has not been evaluated as a nutritional ingredient, and no macronutrient, micronutrient, vitamin, or mineral data are reported in the available scientific literature for any plant part. The phytochemical profile of leaf essential oils is the best-characterized fraction and is dominated by sesquiterpenes and monoterpenes: germacrene D (14.6%), limonene (12.5%), trans-2-hexenal (11.3%), β-elemene (9.2%), 2-undecanone (9.2%), myrcene (7.9%), bicyclogermacrene (7.5%), and germacrene A (5.2%), as quantified by GC-MS. Stem bark and leaf fractions contain alkaloids and other secondary metabolites across apolar and medium-polarity chemical classes, including three novel compounds identified in isolation studies, but concentrations and structural characterizations are not fully disclosed in available abstracts. Bioavailability of any constituent following oral ingestion has not been studied; essential oil terpenes are generally lipophilic and rapidly absorbed through mucous membranes and the gastrointestinal tract, though this is an inference from general terpene pharmacokinetics rather than species-specific data.
How It Works
Mechanism of Action
No specific molecular mechanism of action has been experimentally established for Zanthoxylum rhoifolium. At the compound-class level, benzophenanthridine alkaloids characteristic of the Zanthoxylum genus — such as chelerythrine — are known to intercalate DNA, inhibit protein kinase C, and exhibit antimicrobial activity via membrane disruption, though these actions have not been confirmed for alkaloids isolated specifically from Z. rhoifolium. Alkamide constituents in related species (notably hydroxy-α-sanshool in Z. clava-herculis) activate TRPV1 and TRPA1 transient receptor potential channels on sensory neurons, producing a characteristic tingling and subsequent desensitization that underlies the analgesic and numbing effects attributed to the genus. The sesquiterpene germacrene D, the dominant volatile component in Z. rhoifolium leaf oil at 14.6%, has been associated in other species with inhibition of pro-inflammatory eicosanoid pathways, though this has not been validated in Z. rhoifolium-specific assay systems.
Clinical Evidence
No clinical trials — Phase I, II, or III — have been conducted in humans using Zanthoxylum rhoifolium or any extract, fraction, or isolated compound attributed specifically to this species. The absence of clinical data means that efficacy for any indication, including its primary categorized use as an analgesic, cannot be substantiated with effect sizes, confidence intervals, or patient outcome metrics. Evidence for analgesic use is extrapolated from the broader Zanthoxylum genus, particularly Z. clava-herculis, for which traditional toothache and pain relief applications are documented ethnobotanically but similarly lack supporting randomized controlled trial data. Confidence in any therapeutic claim for Z. rhoifolium specifically remains very low, and the ingredient should be regarded as a preliminary research candidate requiring pharmacological development before clinical evaluation.
Safety & Interactions
Safety data for Zanthoxylum rhoifolium in mammals, including humans, are essentially absent from the published literature, representing a significant knowledge gap that precludes confident safety characterization. The only toxicity signal identified is lethality to Artemia salina (brine shrimp) in a preliminary bioassay, which suggests bioactive cytotoxic potential but does not directly predict mammalian toxicity or safe human dosage thresholds. No drug interactions, contraindications, or adverse event profiles have been established; extrapolation from related Zanthoxylum species suggests caution with concurrent use of anticoagulants (given genus-level coumarins), and uterotonic alkaloid activities reported in some Rutaceae members warrant avoidance during pregnancy and lactation as a precautionary measure. Until dedicated mammalian toxicology studies, including acute and chronic dose-escalation trials, are conducted for Z. rhoifolium, use as a supplement or therapeutic agent cannot be recommended, and any experimental or traditional use should be approached with significant caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Zanthoxylum rhoifoliumHercules' ClubMamica-cadela (Brazilian common name)TembetarúAroeira-brava
Frequently Asked Questions
What is Hercules' Club (Zanthoxylum rhoifolium) used for?
Zanthoxylum rhoifolium is traditionally categorized as an analgesic herb within the Zanthoxylum genus, which is broadly used in Amazonian and Central American folk medicine for pain relief, toothache, and fever. However, species-specific clinical evidence for Z. rhoifolium is absent; current scientific research is limited to phytochemical profiling of its essential oils and bark alkaloids without confirmed therapeutic outcomes in humans.
What are the main active compounds in Zanthoxylum rhoifolium?
The leaf essential oils of Z. rhoifolium are dominated by sesquiterpenes and monoterpenes, with germacrene D at 14.6%, limonene at 12.5%, trans-2-hexenal at 11.3%, β-elemene at 9.2%, and myrcene at 7.9% identified by GC-MS analysis. Stem bark and leaf extracts also contain alkaloids across apolar and medium-polarity fractions, including three compounds reported as novel structures, though their full characterization and concentrations have not been publicly detailed.
Is Zanthoxylum rhoifolium the same as Zanthoxylum clava-herculis?
No — Zanthoxylum rhoifolium and Zanthoxylum clava-herculis are distinct species that share the common name 'Hercules' Club,' which causes significant confusion in lay and commercial contexts. Z. rhoifolium is a neotropical species native to Central and South America, while Z. clava-herculis is a North American species with a better-documented history of use by Native American peoples for toothache relief via its alkamide constituent hydroxy-α-sanshool.
Are there any clinical trials for Zanthoxylum rhoifolium?
No human clinical trials have been conducted for Zanthoxylum rhoifolium as of the available literature. In vitro screening of its essential oils showed no cytotoxic activity against HepG2, MCF-7, or PC-3 cancer cell lines and no antibacterial activity against standard test organisms, with only a positive brine shrimp lethality result providing any bioactivity signal. The evidence base is purely preliminary and phytochemical in nature.
Is Zanthoxylum rhoifolium safe to use as a supplement?
Safety of Z. rhoifolium has not been established in any mammalian model; the only documented toxicity signal is lethality to Artemia salina in a brine shrimp bioassay, which indicates bioactive potential but does not define a safe human dose. No drug interactions, maximum tolerated doses, or clinical safety studies exist for this species, and its use as a dietary supplement is not currently supported by sufficient evidence to make safety assurances, especially during pregnancy or lactation.
What forms of Hercules' Club (Zanthoxylum rhoifolium) are available as supplements?
Zanthoxylum rhoifolium is typically available as dried bark powder, leaf extracts, and tinctures derived from stem bark and leaves. The extract forms are often standardized to contain alkaloid compounds believed to contribute to the herb's traditional effects. Powder and extract formulations differ in concentration and bioavailability, with extracts generally providing higher levels of active compounds per dose.
Does Hercules' Club interact with pain medications or other common drugs?
Limited direct interaction data exists specifically for Zanthoxylum rhoifolium; however, the herb's alkaloid content and traditional analgesic use suggest potential interactions with opioid pain medications or other CNS-active drugs. Individuals taking prescription pain relievers, sedatives, or anticoagulants should consult a healthcare provider before supplementing with this herb. The lack of comprehensive drug interaction studies makes caution especially important when combining with multiple medications.
Who should avoid taking Hercules' Club (Zanthoxylum rhoifolium) supplements?
Pregnant and nursing women should avoid Hercules' Club due to insufficient safety data and traditional use as a stimulant herb affecting uterine function. Individuals with bleeding disorders or those taking anticoagulant medications may need to exercise caution, as alkaloids in the plant have not been fully characterized for blood-clotting effects. People with severe gastrointestinal conditions should consult a healthcare provider, as the herb's stimulant properties may exacerbate certain digestive issues.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w hercules-club-zanthoxylum-rhoifolium curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
